NCT03268876View on ClinicalTrials.gov

The INFLUENCE of Cytoreduction on PRO in EOC

Active, not recruitingOBSERVATIONAL
Enrollment

70

Participants

Timeline

Start Date

March 3, 2021

Primary Completion Date

December 28, 2025

Study Completion Date

December 31, 2030

Conditions
Epithelial Ovarian Cancer
Trial Locations (3)

5021

Haukeland University Hospital, Bergen

Unknown

Sørlandet sykehus HF, Kristiansand

Stavanger University Hospital, Stavanger

All Listed Sponsors
collaborator

Helse Stavanger HF

OTHER_GOV

collaborator

Sorlandet Hospital HF

OTHER_GOV

lead

Haukeland University Hospital

OTHER